The new treatment with ozanimod (also known as zeposia) will benefit over 12,000 adults who suffer from moderate to severe active ulcerative colitis (UC). NICE’s final draft guidance will see ...

Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...

Bristol-Myers Squibb’s Zeposia (ozanimod) is already tipped for blockbuster sales in its first indication – multiple sclerosis – and new data in ulcerative colitis suggests they could climb ...

Alert FDA Approves Ozanimod (Zeposia) for Ulcerative Colitis Once-daily, oral ozanimod is the first sphingosine-1-phosphate receptor modulator approved for adults with moderately to severely ...

"We talked about maybe a pill, a once daily pill, such as ozanimod [Zaposia; Bristol Myers Squibb], may be a really good option to treat her colitis, and so that's what we go with, a pill that she ...

Ulcerative colitis (UC) is a type of inflammatory bowel ... The S1P receptor modulator Zeposia (ozanimod) is an oral pill that works by targeting specific receptors on immune cells (lymphocytes).

mesalamine enemas are usually the first line therapeutic agents for mild ulcerative colitis with limited distal involvement. However, the patient noted that he was unwilling to administer rectal ...